Excitation/inhibition balance in psychosis

Active Grant Awarded

Award ID
R01MH141275
Recipient
Awarding agency
Obligated
$2,106,268

Award facts

Assistance listing
93.242 Mental Health Research Grants
Completion date 4% complete
Place of performance
Columbus, OH 43210, USA

Award details come from USAspending.gov.

About this award

The Department of Health and Human Services National Institutes of Health National Institute of Mental Health awarded Grant R01MH141275 to The Ohio State University Office of Sponsored Programs, with $2.106268 million obligated on September 9, 2026, under the Mental Health Research Grants program (CFDA 93.242). The project seeks to determine the pathology of functional brain networks and excitation/inhibition (E/I) balance, and the relationships between them, at the individual patient level in psychosis spectrum disorders, using normative modeling. It has two study elements: a secondary analysis of existing spectroscopy data measuring GABA and glutamate metabolites in healthy volunteers, and a multi-site, multi-modal imaging study enrolling 200 patients with psychosis spectrum disorders and 200 healthy volunteers. Its first stated aim is to create lifespan normative models of glutamate and GABA as a framework for studying E/I balance in psychiatric disorders at the individual level. The ultimate completion date is June 30, 2031, and the place of performance is Columbus, Ohio 43210.

Description

Abstract
Disruption in the excitation/inhibition (E/I) balance is suggested as a fundamental pathophysiological mechanism underlying psychosis spectrum disorders, but existing interventions targeting the E/I balance, including neuromodulation, have not been effective. IT is possible that our extant knowledge on E/I balance based on group comparison studies is less likely to accurately reflect E/I balance at the individual level. This translational GAP constitutes major obstacles in identifying precision psychiatry targets and interventions. To address this GAP, this project aims to determine pathology for functional brain networks and for the E/I balance and their relationships at the individual patient level in psychosis spectrum disorders with normative modeling ('brain growth charting'). Our overarching study goal is informed by three principal findings from our own work and other research groups. First, maintenance of the balance between excitation and inhibition plays a critical role in brain dynamics. Second, pharmacological challenge studies show that the E/I balance regulates functional networks and that a disruption in the E/I balance may result in functional network connectivity abnormalities seen in patients with psychosis spectrum disorder. Third, normative modeling captures individual-level pathology but there are no normative models of the E/I balance that is also linked to functional network abnormalities. This project will include two separate study elements. The first is a secondary data analysis of already collected spectroscopy data measuring gaba and glutamate metabolites in health volunteers. The second is a multi-site, multi-modal imaging study enrolling 200 patients with psychosis spectrum disorders and 200 health volunteers. With this design, we will: 1) create normative models of glutamate/gaba across the lifespan as a framework to study the E/I balance in psychiatric disorders at the individual participant level (aim 1); 2) quantify individual-level normative E/I balance deviations and functional brain network deviations in psychosis spectrum disorders and evaluate the relationships between the E/I balance deviation and functional network deviation in psychosis spectrum disorders (aim 2). In an exploratory aim, we will explore the relationship between E/I balance deviations, functional network deviations and several key clinical variables. Creation of a normative reference atlas provides the foundation for countless research applications investigating the E/I balance in vivo. Combining normative E/I balance and functional network measures in psychosis will give US an opportunity to derive disease signatures that enable US to make clinically relevant predictions at the individual level. In this way, the findings of this study will provide the precision psychiatry framework for neuromodulation trials directly targeting E/I imbalance with the goal to normalize functional networks and alleviate clinical symptoms.

Subawards

Subrecipient Amount Awarded
University Of Maryland, Baltimore As mPI, Dr. Laura Rowland will be responsible for the successful implementation of the multi-site study protocol at the MPRC site that includes clinical,… $376,086

Quick answers

Who received award R01MH141275?

R01MH141275 was awarded to The Ohio State University by National Institute of Mental Health (National Institutes of Health) on September 9, 2026.

How much is award R01MH141275 worth?

$2,106,268 has been obligated on R01MH141275.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award